Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125635131 | 12563513 | 1 | I | 20160713 | 20160715 | 20160715 | PER | PHEH2016US017552 | NOVARTIS | 67.00 | YR | M | Y | 0.00000 | 20160716 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125635131 | 12563513 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Unknown | 21588 | |||||||||||
| 125635131 | 12563513 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG, QD | 0 | 37.5 | MG | CAPSULE | QD | ||||||
| 125635131 | 12563513 | 3 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | Unknown | U | 0 | ||||||||||
| 125635131 | 12563513 | 4 | C | FAMOTIDINE. | FAMOTIDINE | 1 | Unknown | U | 0 | ||||||||||
| 125635131 | 12563513 | 5 | C | IMODIUM A-D | LOPERAMIDE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125635131 | 12563513 | 6 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 125635131 | 12563513 | 7 | C | LISINOPRIL AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | Unknown | U | 0 | ||||||||||
| 125635131 | 12563513 | 8 | C | ULTRAVATE | HALOBETASOL PROPIONATE | 1 | Unknown | U | 0 | ||||||||||
| 125635131 | 12563513 | 9 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125635131 | 12563513 | 1 | Gastrointestinal neoplasm |
| 125635131 | 12563513 | 2 | Gastrointestinal neoplasm |
| 125635131 | 12563513 | 3 | Product used for unknown indication |
| 125635131 | 12563513 | 4 | Product used for unknown indication |
| 125635131 | 12563513 | 5 | Product used for unknown indication |
| 125635131 | 12563513 | 6 | Product used for unknown indication |
| 125635131 | 12563513 | 7 | Product used for unknown indication |
| 125635131 | 12563513 | 8 | Product used for unknown indication |
| 125635131 | 12563513 | 9 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125635131 | 12563513 | Drug ineffective | |
| 125635131 | 12563513 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |